Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ongoing trials in Alzheimer's disease.

J J Sramek1, N R Cutler

  • 1California Clinical Trials, 8500 Wilshire Boulevard, 7th Floor, Beverly Hills, CA 90211, USA. jsramek@cctrials:com

Expert Opinion on Investigational Drugs
|November 4, 2000
PubMed
Summary

Researchers are advancing Alzheimer's disease (AD) understanding through lesion analysis and genetic data. New therapeutic strategies beyond symptomatic relief show promise for halting disease progression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Balancing risk and benefit in venous thromboembolism trials: concept for a bivariate endpoint trial design and analytic approach.

Journal of thrombosis and haemostasis : JTH·2013
Same author

Comparative effectiveness and safety of the novel oral anticoagulants: do the pivotal clinical trials point to a new paradigm?

Journal of thrombosis and haemostasis : JTH·2012
Same author

Pharmacokinetics of rizatriptan tablets during and between migraine attacks.

Headache·2004
Same author

Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit.

Journal of neural transmission (Vienna, Austria : 1996)·2002
Same author

Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.

Journal of human hypertension·2002
Same author

Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults.

Journal of clinical pharmacology·2002

Area of Science:

  • Neurology
  • Pathophysiology
  • Genetics

Background:

  • Alzheimer's disease (AD) pathophysiology understanding has been limited since its 1907 description.
  • Lack of clarity has hindered therapeutic drug research, leaving only symptomatic relief.
  • Symptomatic cholinergic strategies offer modest benefits.

Purpose of the Study:

  • To establish a foundation for a comprehensive understanding of Alzheimer's disease.
  • To explore novel therapeutic strategies beyond symptomatic treatments.

Main Methods:

  • Spatio-temporal analysis of cerebral lesions (senile plaques and neurofibrillary tangles).
  • Compilation of genetic data concerning familial Alzheimer's disease.

Main Results:

  • New foundation for understanding Alzheimer's disease pathophysiology.
  • Identification of promising therapeutic strategies including oestrogen replacement, anti-inflammatory agents, free radical scavengers, anti-oxidants, and monoamine oxidase-B (MAO-B) inhibitors.

Conclusions:

  • While symptomatic treatments provide modest benefits, novel strategies are under development.
  • Further research is needed to determine the efficacy of emerging therapies.
  • Strategies targeting underlying biochemical changes in AD are nearing clinical testing and offer hope for meaningful outcomes.

Related Experiment Videos